Filing Details
- Accession Number:
- 0000884905-14-000094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-11-07 11:46:31
- Reporting Period:
- 2014-11-06
- Filing Date:
- 2014-11-07
- Accepted Time:
- 2014-11-07 11:46:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
884905 | Praxair Inc | PX | Industrial Inorganic Chemicals (2810) | 061249050 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1311774 | T James Breedlove | C/O Praxair, Inc. 39 Old Ridgebury Road Danbury CT 06810-5113 | Senior Vp, Gen. Counsel & Sec. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-11-06 | 4,120 | $60.92 | 41,944 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-11-06 | 4,120 | $126.52 | 37,824 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2014-11-06 | 4,120 | $0.00 | 4,120 | $60.92 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2010-02-24 | 2019-02-24 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,715 | Indirect | 401(k) |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $83.89 | 2009-02-26 | 2018-02-26 | 39,300 | 39,300 | Direct |
Common Stock | Stock Option (right to buy) | $76.16 | 2011-02-23 | 2020-02-23 | 16,960 | 16,960 | Direct |
Common Stock | Stock Option (right to buy) | $97.84 | 2012-02-22 | 2021-02-22 | 37,930 | 37,930 | Direct |
Common Stock | Stock Option (right to buy) | $109.68 | 2013-02-28 | 2022-02-28 | 36,095 | 36,095 | Direct |
Common Stock | Stock Option (right to buy) | $110.58 | 2014-02-26 | 2023-02-26 | 29,755 | 29,755 | Direct |
Common Stock | Stock Option (right to buy) | $128.80 | 2015-02-25 | 2024-02-25 | 31,090 | 31,090 | Direct |
Common Stock | Deferred Stock | $0.00 | 1,384 | 1,384 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2018-02-26 | 39,300 | 39,300 | Direct |
2020-02-23 | 16,960 | 16,960 | Direct |
2021-02-22 | 37,930 | 37,930 | Direct |
2022-02-28 | 36,095 | 36,095 | Direct |
2023-02-26 | 29,755 | 29,755 | Direct |
2024-02-25 | 31,090 | 31,090 | Direct |
1,384 | 1,384 | Direct |
Footnotes
- The $126.52 price reported is the weighted average sale price. The sale prices ranged from $126.508 to $126.524 per share. Upon request of the SEC Staff, Praxair, Inc. or a security holder of Praxair, Inc., the reporting person will provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.
- This option vests over three years in three consecutive equal annual installments beginning on February 28, 2013.
- This option vests over three years in three consecutive equal annual installments beginning on February 26, 2014.
- This option vests over three years in three consecutive equal annual installments beginning on February 25, 2015.
- Conversion to Praxair Common Stock is on a 1-for-1 basis.
- Deferred stock units acquired under the Praxair, Inc. Compensation Deferral Program as amended ("Deferral Program") and are to be settled in Praxair Common Stock.